Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts-Reference-Cited by-同舟云学术

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts

Published:2017-07-24 Issue: Volume:9 Page:
ISSN:1663-4365
Container-title:Frontiers in Aging Neuroscience
language:
Short-container-title:Front. Aging Neurosci.

Author:

Lue Lih-Fen,Sabbagh Marwan N.,Chiu Ming-Jang,Jing Naomi,Snyder Noelle L.,Schmitz Christopher,Guerra Andre,Belden Christine M.,Chen Ta-Fu,Yang Che-Chuan,Yang Shieh-Yueh,Walker Douglas G.,Chen Kewei,Reiman Eric M.

Publisher

Frontiers Media SA

Subject

Cognitive Neuroscience,Ageing

Reference55 articles.

1. Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer’s disease: a multicenter study in Spain.;Alcolea;J. Alzheimers Dis.,2014

2. Post-dural (post-lumbar) puncture headache: risk factors and clinical features.;Amorim;Cephalalgia,2012

3. The Alzheimer’s Disease Neuroimaging Initiative phase 2: increasing the length, breadth, and depth of our understanding.;Beckett;Alzheimers Dement.,2015

4. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer’s disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.;Bibl;Electrophoresis,2004

5. Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer’s disease: a multicenter assessment.;Blennow;J. Nutr. Health Aging,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Inflammasome Adaptor Protein ASC in Plasma as a Biomarker of Early Cognitive Changes;International Journal of Molecular Sciences;2024-07-16

2. Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline;Frontiers in Aging Neuroscience;2024-05-17

3. The free plasma amyloid Aβ1–42/Aβ1–40 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ1–42/Aβ1–40 ratio. The BALTAZAR study;Neurobiology of Disease;2024-04

4. Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia Society;Journal of the Formosan Medical Association;2024-01

5. A mathematical model on Aβ blood–brain transport: Simulations of plaques’ formation in Alzheimer’s disease;Medical Hypotheses;2023-12